Atrás

Watch Compare

SPRUCE BIOSCIENCES, INC.

Calidad de datos: 100%

SPRB

Nasdaq Manufacturing Chemicals

$66.61

▲ $3.06 (4.82%)

Cap. Mercado: 91.38 M

Precio

$66.61

Cap. Mercado

91.38 M

Rango del Día

$63.50 — $67.96

Rango de 52 Semanas

$7.00 — $1,777.50

Volumen

77,585

Apertura $63.50

Promedio 50D / 200D

$66.09

0.78% above

Promedio 50D / 200D

$140.75

52.68% below

Quick Summary

Puntos Clave

Debt/Equity of 0.10 — conservative balance sheet

Negative free cash flow of -33.33 M

Crecimiento

Revenue Growth (5Y)

N/A

Revenue (1Y)-100.00%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Calidad

Return on Equity

-419.76%

Below sector avg (-51.02%)

ROIC-293.65%

Net MarginN/A

Op. MarginN/A

Seguridad

Debt / Equity

0.10

Below sector avg (0.33)

Current Ratio1.54

Interest Coverage-405.70

Valoración

PE (TTM)

-2.35

Below sector avg (-1.98)

P/B Ratio16.97

EV/EBITDAN/A

Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)

Métrica	Acción	Mediana del Sector
P/E	-2.4	-2.0
P/B	17.0	5.1
ROE %	-419.8	-51.0
Net Margin %	—	-150.2
Rev Growth 5Y %	—	9.3
D/E	0.1	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-100.00%	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	0.0	Net Income (TTM)	-38.97 M
ROE	-419.76%	ROA	-209.87%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-33.33 M
ROIC	-293.65%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.10	Current Ratio	1.54
Interest Coverage	-405.70	Asset Turnover	0.00
Working Capital	5.09 M	Tangible Book Value	5.39 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-2.35	Forward P/E	N/A
P/B Ratio	16.97	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-36.47%
Market Cap	91.38 M	Enterprise Value	81.26 M
Per Share
EPS (Diluted TTM)	-50.83	Revenue / Share	0.00
FCF / Share	-24.29	OCF / Share	-24.29
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	85.53%
SBC-Adj. FCF	-35.35 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	0.0	4.91 M	10.09 M	—	—
Net Income	-38.97 M	-53.04 M	-47.92 M	-46.18 M	-42.29 M
EPS (Diluted)	-50.83	-1.29	-1.24	-1.96	—
Gross Profit	—	—	—	—	—
Operating Income	-36.51 M	-56.15 M	-51.99 M	-47.28 M	-42.07 M
EBITDA	—	—	—	—	—
R&D Expenses	19.52 M	46.42 M	49.43 M	35.20 M	30.70 M
SG&A Expenses	—	—	—	—	—
D&A	21,000.0	46,000.0	70,000.0	74,000.0	68,000.0
Interest Expense	90,000.0	307,000.0	483,000.0	420,000.0	345,000.0
Income Tax	0.0	0.0	0.0	0.0	0.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	53.02 M	45.21 M	103.95 M	85.65 M	126.49 M
Total Liabilities	10.51 M	16.39 M	27.44 M	17.16 M	15.12 M
Shareholders' Equity	42.52 M	28.82 M	76.51 M	68.49 M	111.37 M
Total Debt	0.0	1.84 M	3.71 M	5.64 M	4.88 M
Cash & Equivalents	48.91 M	38.75 M	96.34 M	24.49 M	42.75 M
Current Assets	52.11 M	44.21 M	102.18 M	83.61 M	91.90 M
Current Liabilities	10.09 M	15.25 M	24.47 M	12.45 M	8.87 M